Milestone Metrics for Growth Stage Companies

03 November 2010 Past Event

In today’s business climate, medical device and life sciences companies need to be properly positioned at each phase of development with the appropriate plans in place for later portfolio development stages. Panelists will review key business and intellectual property management tools and strategies that are needed at the early-, mid- and late-growth stages as well the types of funding needed to fuel growth throughout the product life cycle. We also will address how and when you should plan for an IPO as well as other exit strategies, including merger and acquisitions.

Topics include:

  • How companies can balance the need to continually innovate while minimizing the failure rate
  • How to realize revenue streams earlier in the process
  • How to evaluate innovation based on potential business value


  • Jeff Draa, Board of Directors, Tech Coast Angels
  • Gabor Garai, Partner, Foley & Lardner
  • Vanessa Herbert, Senior Manager, PricewaterhouseCoopers
  • Keith Lindenbaum, Partner, Foley & Lardner LLP
  • Robert Mashal, M.D., President & CEO, NKT Therapeutics
  • David Parrot, M.B.A., Managing Director, BMO Capital Markets Corp.


Telehealth: Medicare Finalizes New Services for 2020 in Physician Fee Schedule
11 November 2019
Health Care Law Today
Longstanding EB-5 Visa Program Undergoes Significant Changes
11 November 2019
Labor & Employment Law Perspectives
State Data Breach Notification Laws
11 November 2019
DOJ Announces Procurement Collusion Strike Force
08 November 2019
Legal News: Government Enforcement Defense & Investigations
PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
Fall NAIC Meeting Reception
07 December 2019
Austin, TX